{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:49:55Z","timestamp":1780426195185,"version":"3.54.1"},"reference-count":55,"publisher":"Frontline Medical Communications, Inc.","issue":"1","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cutaneous Medicine and Surgery"],"published-print":{"date-parts":[[2001,3]]},"DOI":"10.1053\/sder.2001.23093","type":"journal-article","created":{"date-parts":[[2007,1,6]],"date-time":"2007-01-06T12:11:19Z","timestamp":1168085479000},"page":"27-37","source":"Crossref","is-referenced-by-count":53,"title":["Localized and systemic scleroderma"],"prefix":"10.12788","volume":"20","author":[{"given":"Anne","family":"Hawk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Joseph C.","family":"English","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5043","reference":[{"key":"10.1053\/sder.2001.23093_bib1","author":"Pusey","year":"1933"},{"key":"10.1053\/sder.2001.23093_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0025-7125(05)70508-3","article-title":"Scleroderma and related conditions","volume":"81","author":"Mitchell","year":"1997","journal-title":"Med Clin North Am"},{"key":"10.1053\/sder.2001.23093_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0190-9622(96)90689-1","article-title":"Guidelines of care for scleroderma and sclerodermoid disorders","volume":"35","author":"Drake","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/sder.2001.23093_bib4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1085-5629(99)80019-4","article-title":"Morphea and localized scleroderma in children","volume":"18","author":"Vierra","year":"1999","journal-title":"Semin Cutan Med Surg"},{"key":"10.1053\/sder.2001.23093_bib5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sder.2001.23093_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1085-5629(98)80058-8","article-title":"Classification and epidemiology of scleroderma","volume":"17","author":"Mayes","year":"1998","journal-title":"Semin Cutan Med Surg"},{"key":"10.1053\/sder.2001.23093_bib7","first-page":"73","article-title":"The epidemiology of morphea (localized scleroderma) in Olmstead Country, 1960\u20131993","volume":"24","author":"Peterson","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1053\/sder.2001.23093_bib8","first-page":"2023","article-title":"Scleroderma","volume":"vol 2","author":"Tu","year":"1998"},{"key":"10.1053\/sder.2001.23093_bib9","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","article-title":"Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States","volume":"41","author":"Lawrence","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sder.2001.23093_bib10","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/art.1780400421","article-title":"Racial differences in scleroderma among women in Michigan","volume":"40","author":"Laing","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sder.2001.23093_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1445-5994.1999.tb01587.x","article-title":"Systemic sclerosis prevalence and mortality in Sydney 1974\u20131988","volume":"29","author":"Englert","year":"1999","journal-title":"Aus NZ J Med"},{"key":"10.1053\/sder.2001.23093_bib12","first-page":"2348","article-title":"Geographical clustering of mortality from systemic sclerosis in the Southeastern United States, 1981\u20131990","volume":"24","author":"Walsh","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1053\/sder.2001.23093_bib13","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/art.1780390814","article-title":"Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype","volume":"39","author":"Arnett","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sder.2001.23093_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S1085-5629(98)80060-6","article-title":"Management of localized scleroderma","volume":"17","author":"Hunzelmann","year":"1998","journal-title":"Semin Cutan Med Surg"},{"key":"10.1053\/sder.2001.23093_bib15","series-title":"Harrison's Principles of Internal Medicine","first-page":"1888","article-title":"Systemic sclerosis (scleroderma)","author":"Gilliland","year":"1998"},{"key":"10.1053\/sder.2001.23093_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/clin.1996.4322","article-title":"Mechanism of serum-mediated endothelial injury in scleroderma: identification of a granular enzyme in scleroderma skin and sera","volume":"83","author":"Kaheleh","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1053\/sder.2001.23093_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2249.2000.01115.x","article-title":"Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): Association with pulmonary fibrosis","volume":"119","author":"Ihn","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/sder.2001.23093_bib18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1177\/000331979704801105","article-title":"ET-1 plasma levels during cold stress test in sclerodermic patients","volume":"48","author":"Danese","year":"1997","journal-title":"Angiology"},{"key":"10.1053\/sder.2001.23093_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00002281-199911000-00010","article-title":"Abnormalities of adhesion molecules and chemokines in scleroderma","volume":"11","author":"Sato","year":"1999","journal-title":"Curr Opin Rheumatol"},{"key":"10.1053\/sder.2001.23093_bib20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00002281-199911000-00009","article-title":"Serologic abnormalities in systemic sclerosis","volume":"11","author":"Harvey","year":"1999","journal-title":"Curr Opin Rheumatol"},{"key":"10.1053\/sder.2001.23093_bib21","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/00002281-199711000-00010","article-title":"Role of metalcatalyzed oxidation reactions in early pathogenesis of scleroderma","volume":"9","author":"Rosen","year":"1997","journal-title":"Curr Opin Rheumatol"},{"key":"10.1053\/sder.2001.23093_bib22","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/00002281-199811000-00011","article-title":"Biology of the scleroderma fibroblast","volume":"10","author":"Strehlow","year":"1998","journal-title":"Curr Opin Rheumatol"},{"key":"10.1053\/sder.2001.23093_bib23","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/00002281-199811000-00010","article-title":"Microchimerism and the pathogenesis of systemic sclerosis","volume":"10","author":"Nelson","year":"1998","journal-title":"Curr Opin Rheumatol"},{"key":"10.1053\/sder.2001.23093_bib24","first-page":"705","article-title":"Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum","volume":"93","author":"Bianchi","year":"1996"},{"key":"10.1053\/sder.2001.23093_bib25","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00007611-199905000-00004","article-title":"Systemic sclerosis from autoimmunity to alloimmunity","volume":"92","author":"Famularo","year":"1999","journal-title":"South Med J"},{"key":"10.1053\/sder.2001.23093_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1445-5994.1999.tb01586.x","article-title":"Familial risk estimation in systemic sclerosis","volume":"29","author":"Englert","year":"1999","journal-title":"Aus NZ J Med"},{"key":"10.1053\/sder.2001.23093_bib27","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/1529-0131(199810)41:10<1729::AID-ART5>3.0.CO;2-8","article-title":"Association of microsatellite markers near the fibrillin I gene on human chromosome 15q with scleroderma in a Native American population","volume":"41","author":"Tan","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sder.2001.23093_bib28","first-page":"27","article-title":"Localized scleroderma","volume":"17","author":"Tuffanelli","year":"1998"},{"key":"10.1053\/sder.2001.23093_bib29","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00002281-199711000-00013","article-title":"Eosinophilia-myalgia syndrome, eosinophilic fasciitis, and related fibrosing disorders","volume":"9","author":"Varga","year":"1997","journal-title":"Curr Opin Rheumatol"},{"key":"10.1053\/sder.2001.23093_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1085-5629(98)80062-X","article-title":"Clinical manifestations of systemic sclerosis","volume":"17","author":"Steen","year":"1998","journal-title":"Semin Cutan Med Surg"},{"key":"10.1053\/sder.2001.23093_bib31","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2249.1999.00961.x","article-title":"Distribution and antigen specificity of anti-U1RNP antibodies in patients with systemic sclerosis","volume":"117","author":"Ihn","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/sder.2001.23093_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0190-9622(98)70077-5","article-title":"Topical calcipotriene for morphea\/linear scleroderma","volume":"39","author":"Cunningham","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/sder.2001.23093_bib33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0190-9622(97)80221-6","article-title":"Double-blind, placebo-controlled study of intralesional interferon gamma for the treatment of localized scleroderma","volume":"36","author":"Hunzelmann","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/sder.2001.23093_bib34","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archderm.1990.01670290053007","article-title":"D-penicillamine in the treatment of localized scleroderma","volume":"126","author":"Falanga","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1053\/sder.2001.23093_bib35","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0190-9622(98)70079-9","article-title":"Lowdose methotrexate in the treatment of widespread morphea","volume":"39","author":"Seyger","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/sder.2001.23093_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0190-9622(98)70533-X","article-title":"Low-dose UVA1 phototherapy for treatment of localized scleroderma","volume":"38","author":"Kerscher","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/sder.2001.23093_bib37","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archderm.1996.03890350014001","article-title":"PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients","volume":"132","author":"Kerscher","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1053\/sder.2001.23093_bib38","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0190-9622(97)70193-2","article-title":"Psoralen UVA therapy for linear and gencralized morphea","volume":"37","author":"Morrison","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/sder.2001.23093_bib39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/000155500750012469","article-title":"Topical photodynamic therapy for localized scleroderma","volume":"80","author":"Karrer","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"10.1053\/sder.2001.23093_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1085-5629(98)80063-1","article-title":"Management of systemic sclerosis: The art and the science","volume":"17","author":"Stone","year":"1998","journal-title":"Semin Cutan Med Surg"},{"key":"10.1053\/sder.2001.23093_bib41","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1529-0131(199804)41:4<670::AID-ART14>3.0.CO;2-I","article-title":"Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis","volume":"41","author":"Wigley","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sder.2001.23093_bib42","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/rheumatology\/38.10.992","article-title":"Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy","volume":"38","author":"Filaci","year":"1999","journal-title":"Rheumatology"},{"key":"10.1053\/sder.2001.23093_bib43","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/S0140-6736(05)60391-1","article-title":"Advances in the treatment of systemic sclerosis","volume":"352","author":"Herrick","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/sder.2001.23093_bib44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1085-5629(98)80016-3","article-title":"Clinical approach to scleroderma","volume":"17","author":"White","year":"1998","journal-title":"Semin Cutan Med Surg"},{"key":"10.1053\/sder.2001.23093_bib45","doi-asserted-by":"crossref","first-page":"871","DOI":"10.7326\/0003-4819-132-11-200006060-00004","article-title":"Recombinant human relaxin in the treatment of scleroderma: a randomized, double-blind, placebo-controlled trial","volume":"132","author":"Seibold","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1053\/sder.2001.23093_bib46","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1046\/j.1365-2133.1998.02460.x","article-title":"Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicenter trial","volume":"139","author":"Grasseger","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1053\/sder.2001.23093_bib47","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archderm.1997.03890410065008","article-title":"Systemic scleroderma: multicenter trial of 1 year of treatment with recombinant interferon gamma","volume":"133","author":"Hunzelmann","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1053\/sder.2001.23093_bib48","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0190-9622(99)70246-X","article-title":"Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photophoresis)","volume":"41","author":"Enomoto","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/sder.2001.23093_bib49","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(05)79828-7","article-title":"Minocycline in early diffuse scleroderma","volume":"352","author":"Le","year":"1998","journal-title":"Lancet"},{"issue":"suppl 48","key":"10.1053\/sder.2001.23093_bib50","first-page":"72","article-title":"Development of a protocol for allogenic marrow transplantation for severe systemic sclerosis: paradigm for autoimmune disease","volume":"24","author":"Nash","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1053\/sder.2001.23093_bib51","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0140-6736(05)64864-7","article-title":"Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation","volume":"349","author":"Tyndall","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/sder.2001.23093_bib52","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/ard.57.11.682","article-title":"Mortality and causes of death in a Swedish series of systemic sclerosis patients","volume":"57","author":"Hesselstrand","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/sder.2001.23093_bib53","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/rheumatology\/37.7.750","article-title":"Morality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma)","volume":"37","author":"Jacobsen","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1053\/sder.2001.23093_bib54","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1002\/1529-0131(199912)42:12<2660::AID-ANR23>3.0.CO;2-N","article-title":"Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit","volume":"42","author":"Bryan","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1053\/sder.2001.23093_bib55","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/ard.56.12.723","article-title":"Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis","volume":"56","author":"Simeon","year":"1997","journal-title":"Ann Rheum Dis"}],"container-title":["Seminars in Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562901800055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562901800055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scmsjournal.com\/wp-content\/uploads\/2016\/09\/v20i1-Hawk.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T15:10:06Z","timestamp":1616166606000},"score":1,"resource":{"primary":{"URL":"http:\/\/scmsjournal.com\/article\/buy_now\/?id=633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["S1085562901800055"],"URL":"https:\/\/doi.org\/10.1053\/sder.2001.23093","relation":{},"ISSN":["1085-5629"],"issn-type":[{"value":"1085-5629","type":"print"}],"subject":[],"published":{"date-parts":[[2001,3]]}}}